Deletion of BCATm increases insulin-stimulated glucose oxidation in the heart

Golam M. Uddin; Qutuba G. Karwi; Simran Pherwani; Keshav Gopal; Cory S. Wagg; Dipsikha Biswas; Mariam Atnasious; Yikuan Wu; Guoqing Wu; Liyan Zhang; Kim L. Ho; Thomas Pulinilkunnil; John R. Ussher; Gary D. Lopaschuk

doi:10.1016/j.metabol.2021.154871

Deletion of BCATm increases insulin-stimulated glucose oxidation in the heart

Golam M. Uddin, Qutuba G. Karwi, Simran Pherwani, Keshav Gopal, Cory S. Wagg, Dipsikha Biswas, Mariam Atnasious, Yikuan Wu, Guoqing Wu, Liyan Zhang, Kim L. Ho, Thomas Pulinilkunnil, John R. Ussher, Gary D. Lopaschuk

Office of Academic Affairs

Research output: Contribution to journal › Article › peer-review

25 Citations (Scopus)

Original language	English
Article number	154871
Journal	Metabolism: Clinical and Experimental
Volume	124
DOIs	https://doi.org/10.1016/j.metabol.2021.154871
Publication status	Published - Nov 2021

ASJC Scopus Subject Areas

Endocrinology, Diabetes and Metabolism
Endocrinology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.metabol.2021.154871

Cite this

Uddin, G. M., Karwi, Q. G., Pherwani, S., Gopal, K., Wagg, C. S., Biswas, D., Atnasious, M., Wu, Y., Wu, G., Zhang, L., Ho, K. L., Pulinilkunnil, T., Ussher, J. R., & Lopaschuk, G. D. (2021). Deletion of BCATm increases insulin-stimulated glucose oxidation in the heart. Metabolism: Clinical and Experimental, 124, Article 154871. https://doi.org/10.1016/j.metabol.2021.154871

@article{df589b9daa4e4456aab80bbe6573ca65,

title = "Deletion of BCATm increases insulin-stimulated glucose oxidation in the heart",

author = "Uddin, {Golam M.} and Karwi, {Qutuba G.} and Simran Pherwani and Keshav Gopal and Wagg, {Cory S.} and Dipsikha Biswas and Mariam Atnasious and Yikuan Wu and Guoqing Wu and Liyan Zhang and Ho, {Kim L.} and Thomas Pulinilkunnil and Ussher, {John R.} and Lopaschuk, {Gary D.}",

note = "Funding Information: We thank Dr. Susan M. Hutson (Virginia Polytechnic Institute and State University) for kindly providing us with the BCATmflox mice line. All animal protocols were approved by the University of Alberta Institutional Animal Care and Use Committee, which conform with the Guide for the Care and Use of Laboratory Animals published by the United States National Institutes of Health (eighth edition; revised 2011) and the guidelines of the Canadian Council on Animal Care. This study was supported by a grant from the Heart and Stroke Foundation of Canada to GDL. All data are available in the Lopaschuk Laboratory. Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Gary D. Lopaschuk (glopasch@ualberta.ca). Funding Information: This study was supported by a grant from the Heart and Stroke Foundation of Canada to GDL. Publisher Copyright: {\textcopyright} 2021",

year = "2021",

month = nov,

doi = "10.1016/j.metabol.2021.154871",

language = "English",

volume = "124",

journal = "Metabolism: Clinical and Experimental",

issn = "0026-0495",

publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Deletion of BCATm increases insulin-stimulated glucose oxidation in the heart

AU - Uddin, Golam M.

AU - Karwi, Qutuba G.

AU - Pherwani, Simran

AU - Gopal, Keshav

AU - Wagg, Cory S.

AU - Biswas, Dipsikha

AU - Atnasious, Mariam

AU - Wu, Yikuan

AU - Wu, Guoqing

AU - Zhang, Liyan

AU - Ho, Kim L.

AU - Pulinilkunnil, Thomas

AU - Ussher, John R.

AU - Lopaschuk, Gary D.

N1 - Funding Information: We thank Dr. Susan M. Hutson (Virginia Polytechnic Institute and State University) for kindly providing us with the BCATmflox mice line. All animal protocols were approved by the University of Alberta Institutional Animal Care and Use Committee, which conform with the Guide for the Care and Use of Laboratory Animals published by the United States National Institutes of Health (eighth edition; revised 2011) and the guidelines of the Canadian Council on Animal Care. This study was supported by a grant from the Heart and Stroke Foundation of Canada to GDL. All data are available in the Lopaschuk Laboratory. Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Gary D. Lopaschuk (glopasch@ualberta.ca). Funding Information: This study was supported by a grant from the Heart and Stroke Foundation of Canada to GDL. Publisher Copyright: © 2021

PY - 2021/11

Y1 - 2021/11

UR - http://www.scopus.com/inward/record.url?scp=85114414512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85114414512&partnerID=8YFLogxK

U2 - 10.1016/j.metabol.2021.154871

DO - 10.1016/j.metabol.2021.154871

M3 - Article

C2 - 34478752

AN - SCOPUS:85114414512

SN - 0026-0495

VL - 124

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

M1 - 154871

ER -

Deletion of BCATm increases insulin-stimulated glucose oxidation in the heart

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this